Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × infigratinib × Clear all

Sponsor

Conditions

Glioblastoma 2 Cholangiocarcinoma 2 Upper Tract Urothelial Carcinomas 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Glioma 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡